Who to call at Goldenwell Biotech, Inc., and when
Fundz watches for the moments Goldenwell Biotech, Inc. starts buying, and tells you who to reach.
- An alert the day Goldenwell Biotech, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Goldenwell Biotech, Inc., from your own LinkedIn network
Goldenwell Biotech, Inc.
The company changed its auditor. An 8-K is the notice a US public company must file within four business days of a major event.
goldenwellbiotech.comAI Executive Summary
AI-powered analysis of 8-K filing content
Goldenwell Biotech dismissed its independent auditor Michael Gillespie & Associates on September 27, 2026, and engaged Privatco CPA Limited as replacement. While no disagreements or adverse opinions were noted, the prior auditor had expressed substantial doubt about the company's ability to continue as a going concern, signaling potential financial distress.
Key Takeaways
Auditor dismissal follows going concern warnings in prior year reports, indicating ongoing viability concerns despite no formal disagreements
Board-approved change to new auditor Privatco CPA Limited suggests strategic shift in accounting oversight and financial reporting approach
2 more takeaways
Related Filings (1)
1 more filing from Goldenwell Biotech, Inc. in the last 90 days
Filing Overview
What This Means
Goldenwell Biotech, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.